Placeholder Banner

BIO Letter to Senate on Key Priorities for Fiscal Year 2023 Agriculture, Rural Development, FDA and Related Agencies Appropriations Act

May 4, 2022

BIO supports public policies centered on innovation to incentivize the adoption of cutting-edge technologies and practices to maintain America’s leadership and benefit our rural economies. Further, it is crucial that the government establish risk-proportionate, transparent regulations in a timely manner that spur biological innovations and biobased technologies while protecting health and the environment.

As such, BIO urges the committee to actively support the following priorities as it develops the Fiscal Year 2023 (FY 2023) Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act:

Download Full Comments Below
FY23 BIO Senate AgFDA Request Letter
Discover More
BIO and the American Seed Trade Association submitted comments on USDA-APHIS' proposed exemptions of five types of genetic modifications a plant can contain and be exempt from regulations for the movement of organisms modified or produced through…
BIO joined with other groups in writing House and Senate Agriculture Committee leaders in support of agricultural research (FFAR) funding in the farm bill. 
BIO and 59 other organizations have written to House and Senate Agriculture Committee leaders to ask that they direct Congress to withdraw the current rule concerning regulation of plant incorporated protectants and replace it one based on a science…